Endocyte, Inc. (ECYT) Adds David Meek as Chief Commercial Officer
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte, Inc. (Nasdaq: ECYT) announced the appointment of David Meek to the newly created position of chief commercial officer. Mr. Meek will be responsible for the development of Endocyte's commercial team and the Company's overall commercial strategy and execution.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SCI Engineered Materials CFO resigns after four months in role
- Resideo names Shane Harrison as CFO, effective September 1
- Fermi names Lee McIntire as CEO, effective August 11
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
